Clinical trial
Clinical Evaluation of the CARTO™ XP EP Navigation System v9 and Biosense…
NCT00449085 · Biosense Webster, Inc., Industry · Withdrawn
Key facts
| NCT number | NCT00449085 |
|---|---|
| Title | Clinical Evaluation of the CARTO™ XP EP Navigation System v9 and Biosense Webster SOUNDSTAR 3D Diagnostic Ultrasound. A Feasibility Study |
| Official title | Clinical Evaluation of the CARTO™ XP EP Navigation System v9 and Biosense Webster SOUNDSTAR 3D Diagnostic Ultrasound. A Feasibility Study |
| Lead sponsor | Biosense Webster, Inc., Industry |
| Collaborators | Royal Adelaide Hospital Melbourne Health |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cardiac Arrhythmias |
| Intervention type | Device, Procedure |
| Interventions | Electrophysiology, CARTO™ XP EP Navigation System V9 |
| Enrollment | 0 |
| Start date | Apr 1, 2007 |
| Primary completion | Jul 1, 2012 |
| First posted | Mar 19, 2007 |
| Last update posted | Feb 3, 2025 |
At a glance
- No Results posted
- 10–99 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: